Clinical trials are prospective biomedical or behavioural research studies involving human subjects that aim to provide answers to particular questions about biomedical or behavioural interventions. These include both established and novel treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) as well as interventions that have already been tried and tested but still require more research and comparison. Data on dosage, safety, and effectiveness are produced by clinical trials. In the nation where therapy approval is sought, they are only carried out after receiving approval from the health authority or ethics committee. These authorities are in charge of evaluating the trial's risk/benefit ratio; their approval merely permits the trial to proceed and does not imply that the therapy is "safe" or effective. In small pilot studies, researchers first enrol volunteers or patients, depending on the product type and stage of development.
Speaker lineup for this track will be announced soon.
Browse all speakers →Introduction: Effect size is, an important consideration in the sample size estimation while designing randomized controlled trials using a frequentist approach. This study aims to systematically…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Clinical Trials work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Clinical Trials research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Clinical Trials track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Clinical Trials. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Clinical Trials are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Clinical Trials track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
